SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000891293-21-000013
Filing Date
2021-04-09
Accepted
2021-04-09 16:26:48
Documents
5
Period of Report
2021-04-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A ctic-2021proxystatementpre.htm PRE 14A 757784
2 acraignsignaturea051.jpg GRAPHIC 8270
3 ctia011.jpg GRAPHIC 5054
4 cticproxycard1.jpg GRAPHIC 136188
5 cticproxycard21.jpg GRAPHIC 139055
  Complete submission text file 0000891293-21-000013.txt   1156767
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-28386 | Film No.: 21818122
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences